| Value | ₹137.2 Cr |
|---|---|
| Execution period | 18 months |
BSE filing, NSE: INDSWFTLAB. Summary written from the filing by ALFA Finder's alert engine.
Ind-Swift Laboratories Ltd: key numbers
- Share price
- ₹377.40
- Market cap
- ₹3,282 Cr
- Revenue (annual)
- ₹649.1 Cr
- Net profit (annual)
- ₹43.12 Cr
- P/E (TTM)
- 57.2×Sector 46.5×
- Promoter holding
- 42.93%+0.00% QoQ
- FII holding
- 10.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ind-Swift Laboratories Ltd
All →Ind-Swift Laboratories Board Meeting Date
Ind-Swift Laboratories Ltd. scheduled a board meeting for October 29, 2026, to consider and approve the standalone and consolidated financial results for the quarter and half-year.
Ind-Swift Laboratories Convertible Warrants
Essix Biosciences Limited acquired 14,00,000 equity shares of Ind-Swift Laboratories Limited following the conversion of fully convertible warrants. The company disclosed this under SEBI regulations.
Ind-Swift Laboratories Capital Structure Change
Ind-Swift Laboratories allotted 14,00,000 equity shares upon conversion of warrants at Rs. 196 each. The allotment follows a previously approved preferential issue.
- Value
- ₹27.44 Cr
Ind-Swift Laboratories Capital Structure Change
Ind-Swift Laboratories allotted 14 lakh equity shares upon converting warrants for Essix Biosciences Limited, receiving ₹20.58 Crore. This increases the company's paid-up equity share capital.
- Value
- ₹20.58 Cr
Ind-Swift Laboratories Annual General Meeting
Ind-Swift Laboratories Limited held its 31st Annual General Meeting on September 30, 2026. Members approved audited financial statements and director appointments.
Ind-Swift Laboratories Other Announcement
KMP Pardeep Verma sold 6,140 equity shares of Ind-Swift Laboratories Ltd via market sale, reducing his holding by 0.01%.
- Value
- ₹0.25 Cr
Other capital structure change announcements
All →Hero MotoCorp Capital Structure Change
Hero MotoCorp's board approved up to ₹300 Crore additional investment in wholly-owned subsidiary HMCL Netherlands B.V., in tranches over two years. Quarterly results were also approved.
- Value
- ₹300.0 Cr
- Execution
- 2 years, in one or more tranches
Great Eastern Shipping Company Capital Structure Change
Great Eastern Shipping bought back 88,877 equity shares on 28 October 2026 at an average of Rs.1,529.71. Total shares bought back under the open-market buyback now stand at 38,48,494.
- Value
- ₹13.60 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme bought back 64,583 shares on 28-10-2026 at an average ₹262.49, totalling 23,56,451 shares to date. Purchases were made via Emkay Global on the open market.
- Value
- ₹1.70 Cr
Blue Chip Tex Industries Capital Structure Change
Counter Cyclical Investments PMS sold 2,986 shares (0.15%) of Blue Chip Tex via open market, reducing its stake from 5.62% to 5.46%. The filing is a non-promoter SAST Reg 29(2) disclosure.
Swiggy Capital Structure Change
Nippon India Mutual Fund bought about 0.18% of Swiggy, lifting its stake from 4.99% to 5.17%. The disclosure is a non-promoter Reg 29(1) filing covering open-market purchases through October 26, 2026.
- Execution
- Purchase transactions from November 13, 2024 to October 26, 2026
Mahindra Logistics Capital Structure Change
Nippon India Mutual Fund sold 13.76 lakh Mahindra Logistics shares, cutting its stake to 3.05%. The non-promoter disposal was made via open market.